Drugs / TCR-Transduced PBL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04194190 | — | — | National Institutes of Health Clinical Center (CC) | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TCR-Transduced PBL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04194190 ↗ |
| Modality | Cell therapy | “autologous peripheral blood lymphocytes (PBL) that have been transduced with genes encoding T-cell receptors” NCT04194190 ↗ |